Teva Pharmaceutical Industries (NYSE: TEVA) plans to acquire privately held Emalex Biosciences in a deal built around Emalex’s lead drug candidate, ecopipam. Teva will pay…
The Presidential Executive order signed Saturday, directs federal health and drug agencies to accelerate research and review of psychedelic therapies for serious mental illness, with…
Shares of Hims & Hers Health, Inc. (NYSE: HIMS) are ripping higher today, jumping about 37% to $21.61 as the telehealth platform continues to rebound from its February selloff and investors refocus…
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) shares surged after the U.S. Food and Drug Administration approved BYSANTI™ (milsaperidone), a new treatment for adults with bipolar I…
January 20, 2026
NRx Advances Ketamine FDA Submission
NRx Pharmaceuticals (NASDAQ: NRXP) is making waves in the biotechnology sector today, announcing a monumental milestone in its regulatory journey. It is preparing to submit…
January 05, 2026
Helus Pharma Begins Trading on Nasdaq, Advances Therapeutic Innovation in Mental Health
Helus Pharma, originally Cybin Inc., announced that its American Depositary Shares (ADSs) have commenced trading on the Nasdaq Stock Market under the ticker symbol NASDAQ:…
December 16, 2025
Mental Health Care Evolves as Demand Grows and Services Diversify
Mental health care is rapidly evolving beyond traditional clinical models as rising awareness, broader acceptance, and a widening range of treatment options draw attention from…